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Tonic endocannabinoid-mediated modulation of
GABA release is independent of the CB1 content
of axon terminals
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& Zoltan Nusser1
The release of GABA from cholecystokinin-containing interneurons is modulated by type-1
cannabinoid receptors (CB1). Here we tested the hypothesis that the strength of CB1-
mediated modulation of GABA release is related to the CB1 content of axon terminals. Basket
cell boutons have on average 78% higher CB1 content than those of dendritic-layer-
innervating (DLI) cells, a consequence of larger bouton surface and higher CB1 density. The
CB1 antagonist AM251 caused a 54% increase in action potential-evoked [Ca
2þ ] in boutons
of basket cells, but not in DLI cells. However, the effect of AM251 did not correlate with CB1
immunoreactivity of individual boutons. Moreover, a CB1 agonist decreased [Ca
2þ ] in a cell
type- and CB1-content-independent manner. Replica immunogold labelling demonstrated the
colocalization of CB1 with the Cav2.2 Ca
2þ channel subunit. Our data suggest that only a
subpopulation of CB1s, within nanometre distances from their target Cav2.2 channels, are
responsible for endocannabinoid-mediated modulation of GABA release.
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T
he effect of a neuroactive substance on its target cells
depends on its spatio-temporal concentration proﬁle, its
afﬁnity to the receptors and the number of receptors on the
target cells. According to this simple view, the more receptors
a cell expresses on its surface, the larger the effect of
the ligand. When this simple model was tested for ion-
channel-forming receptors, it was found that the number of
synaptic AMPA receptors strongly predicts the size of the
postsynaptic AMPA receptor-mediated responses1–6 and that
more synaptic GABAA receptors confer larger postsynaptic
inhibitory responses7,8. The consequence of the activation of
ionotropic receptors can be relatively easily monitored by patch-
clamp electrophysiological or imaging techniques, allowing the
determination of the ‘number–function’ relationships for these
receptors. In contrast to ion-channel-forming receptors, it is
much more challenging to quantify the effects of metabotropic
receptor activation, since they act through second messenger
pathways, which could contain signal ampliﬁcation/saturation
steps. Thus, it is much more difﬁcult to determine their ‘number–
function’ relationships, requiring the quantitative measurement of
their function as well as their numbers in small, functionally
relevant subcellular compartments.
G-protein-coupled receptors (GPCRs) form a diverse family,
with hundreds of genes expressed in the central nervous system9.
A signiﬁcant fraction of GPCRs are located on presynaptic axon
terminals, where they effectively control neurotransmitter
release10–14. The mechanisms of regulation of release have
been extensively studied, revealing numerous mechanisms,
including the direct or indirect modulation of presynaptic
voltage-gated Ca2þ or Kþ channels, or the modiﬁcation of the
release machinery through, for example, phosphorylation11,15–17.
To investigate the ‘number–function’ relationship for a given
GPCR, the mechanisms of action need to be quantitatively
understood.
In a recent study18, we examined the mechanisms of action of
presynaptic type-1 cannabinoid receptors (CB1) on cholecystokinin
(CCK)-expressing GABAergic interneurons (INs) of the CA3
region of the hippocampus. Our results revealed that tonic CB1
activation results in a reduction of Ca2þ inﬂux through N-type
Ca2þ channels (Cav2.2 subunits), which is primarily responsible
for the reduction of GABA release. The change in Ca2þ inﬂux can
be measured with two-photon microscopy at the level of individual
axon terminals in acute slices. It is well known that CB1 is strongly
expressed by a diverse population of hippocampal CCK-positive
(CCKþ ) INs in their axons19, resulting in a sparse axonal labelling
of the hippocampal neuropil. This sparse labelling provides a
unique opportunity for post hoc measurements of the CB1 content
of in vitro imaged boutons. In addition, CB1 seemed to be a
good candidate for such a receptor ‘number–function’ study,
since substantial heterogeneity has been reported in the degree of
CB1 modulation of GABA release from distinct CCKþ IN
subtypes20–22, similar to that of glutamatergic boutons of the
cerebellum23. In addition, the CB1 content of individual boutons
also seems to be variable24,25.
In this study, we quantiﬁed the CB1 content of axon terminals
and found remarkable heterogeneity among individual boutons of
a single cell, individual cells of a single cell type and different cell
types. In addition, the amplitude of action potential (AP)-evoked
[Ca2þ ] and its modulation by CB1 also exhibits substantial
variability within- and between cell types. Basket cell axon
terminals contain more CB1, have smaller [Ca2þ ] transients and
respond more strongly to CB1 antagonism compared with
dendritic-layer-innervating (DLI) cells. Despite this, the
degree of CB1 modulation does not depend on the total amount
of CB1 of axon terminals. We also demonstrate the colocalization
of CB1 with Cav2.2 Ca2þ channel subunit clusters in a conﬁned
area of the presynaptic terminal membranes; this area is likely to
be the presynaptic active zone (AZ).
Results
Variability in CB1 content of CCKþ GABAergic boutons.
Although previous studies have suggested variability in the
CB1 content of GABAergic axons in the CA1 region of the rat
hippocampus24,25, we aimed at providing a systematic,
quantitative analysis of the CB1 content of axon terminals in
distinct layers in the CA3 area (Fig. 1). In low-magniﬁcation
light microscopic (LM) images of hippocampal sections
immunolabelled for CB1, the stratum pyramidale in the distal
CA3 (closer to the CA2 area) appeared more intensely labelled in
many slices than either the dendritic layers or the stratum
pyramidale of the proximal CA3 (closer to the dentate gyrus;
Fig. 1a). To reduce variability in CB1 immunoreactivity (CB1-IR)
originating from differences between distal and proximal CA3
regions, we conﬁned our analysis to the distal part of the CA3
area. Since the appearance of immunoﬂuorescent signal at low
magniﬁcations is the consequence of both the density of boutons
and the CB1-IR of individual boutons, the observed differences in
signal intensities between strata oriens, pyramidale, lucidum and
radiatum do not necessarily reﬂect differences in the CB1 content
of CCKþ axon terminals. To characterize the CB1-IR of
individual boutons, we obtained high-resolution confocal
Z-image stacks and measured the integral of ﬂuorescence (see
Methods) of randomly selected boutons in these four strata in
immersion-ﬁxed mouse slices following in vitro imaging
experiments (Fig. 1a–c,f), and in sections from transcardially
perfused mice (Fig. 1d,g) and rats (Fig. 1e,h). The mean CB1-IR of
individual boutons was signiﬁcantly higher in stratum pyramidale
compared with strata oriens and radiatum in the distal CA3 area
(randomized block analysis of variance (ANOVA): Po0.001,
Tukey post hoc test: Po0.001).
Our ﬂuorescent measurements provide an estimate of the total
CB1 content of the axon terminals, which is a function of the CB1
surface density, the surface area of the bouton and potential
intracellular pool of receptors. Thus, the higher CB1-IR in the
stratum pyramidale (Fig. 1) could be the consequence of an
elevated CB1 density and/or larger boutons and/or more
intracellular receptors. To directly test the CB1 density in
membranes of axon terminals, we have carried out electron
microscopic (EM) freeze-fracture replica immunogold labelling
(SDS-FRL) for CB1 in four distinct layers of the distal CA3 area in
mice (Fig. 2) and rats (Supplementary Fig. 1). Gold particles for
CB1 were enriched in some protoplasmic-face (P-face) membrane
segments, consistent with the cytoplasmic location of the epitope
recognized by the antibodies. Gold particles were apparently
randomly distributed over these CB1-positive fractured mem-
branes, without large areas of elevated or reduced densities
(Fig. 2a–d,f; Supplementary Fig. 1a–d,f). The strongly CB1-
positive P-face membranes are GABAergic, because the CB1-
positive proﬁles were also immunopositive for the vesicular
inhibitory amino-acid transporter (VIAAT or vesicular GABA
transporter; Fig. 2f,g,j; Supplementary Fig. 1f,g). Furthermore, the
CB1-positive proﬁles assumed to be axon terminals of CCKþ
INs for the following reasons: (1) the size of the fractured
membranes is consistent with them being axons, axon terminals,
dendritic spines or small dendrites, but inconsistent with somata,
large or medium diameter dendrites; (2) the frequency of ﬁnding
a CB1-positive proﬁle is inconsistent with the labelling of
excitatory terminals; (3) CB1-positive membranes are often
attached to the somatic exoplasmic-face (E-face) membranes
(Fig. 3c,e; Supplementary Figs 2e and 3a,d), a feature that never
occurs for postsynaptic proﬁles. We quantiﬁed the densities of
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CB1 immunogold particles on P-face structures in all four layers
of the distal CA3 in mice (Fig. 2e) and rats (Supplementary
Fig. 1e) and found that they were signiﬁcantly higher than the
background labelling (one-way ANOVA: Po0.001; Tukey’s post
hoc test: Po0.01) determined on surrounding E-face proﬁles.
Furthermore, the boutons in stratum pyramidale contained
signiﬁcantly higher gold particle densities than those in
strata lucidum and radiatum (randomized block ANOVA,
Po0.05; Tukey’s post hoc test, Po0.05). The speciﬁcity of the
immunolabelling for two antibodies raised against the CB1 was
conﬁrmed using CB1 / and CB1þ /þ mice (see Methods and
Fig. 2h–k). Double labelling for CB1 and the presynaptic AZ
marker Rim1/2 revealed an extensive colocalization (Fig. 3a–d;
Supplementary Fig. 2), providing evidence for the presence of
CB1 in presynaptic AZs. Although it has been demonstrated
that the inﬂux of Ca2þ into CCKþ axon terminals is mediated
by N-type Ca2þ channels18, the exact location of the pore
forming Cav2.2 subunit and its relative position to CB1 is
unknown. Therefore, we performed colocalization of CB1 and
Cav2.2 and found that many CB1-positive terminals also contain
Cav2.2 (Fig. 3e; Supplementary Figs 3c,d and 5). The fact that
not every CB1-positive proﬁle contains Cav2.2 (Fig. 3f;
Supplementary Fig. 3e) is likely to be the consequence of the
lack of AZs in a large fraction (70–80%) of randomly fractured
axon terminal membranes. The Cav2.2-positive proﬁles, however,
were almost always CB1 positive. The segregation of the Cav2.1
and Cav2.2 subunits in axon terminal membrane segments
fractured onto pyramidal cell (PC) somata (Fig. 3g,h;
Supplementary Fig. 3f,g,i) provide morphological evidence for
the exclusive role of these two subunits in parvalbumin and
CCKþ basket cell axon terminals, respectively. The speciﬁcity of
the immunolabelling for Ca2þ channel subunits was conﬁrmed
using knockout animals (for Cav2.2 see Methods and Fig. 3i–k;
for Cav2.1; see ref. 26).
Having established a signiﬁcant difference in the CB1 density of
axon terminals in stratum pyramidale and dendritic layers, we
also investigated whether additional differences in the size of the
boutons exist. We performed three-dimensional (3D) EM
reconstructions of CCKþ boutons from serial ultrathin sections
in the distal CA3 region of the hippocampus (n¼ 22 and 21
boutons in strata pyramidale and radiatum, respectively, n¼ 3
mice; Supplementary Fig. 4). Boutons were usually ﬂat (especially
in stratum pyramidale) and had variable shapes (Supplementary
Fig. 4a,b). Our quantiﬁcation revealed that the surface area of
boutons, the bouton volume, the total AZ area and the number of
AZs per boutons were all signiﬁcantly larger, whereas the total AZ
area—bouton volume ratio and the total AZ area—bouton surface
ratio were smaller in terminals in stratum pyramidale compared
with those in stratum radiatum (Supplementary Fig. 4c–h;
unpaired t-test, Pr0.01). Our 3D reconstructions revealed that
most CCKþ boutons in the stratum pyramidale contained
multiple AZs, which had variable shapes and sizes. Consistent
with this, the shapes and sizes of Rim1/2-immunolabelled AZs
(Fig. 3a–c) and Cav2.2-enriched areas (Fig. 3e; Supplementary
Figs 3c–d,f–g and 5) in our replicas also showed great variability,
and many perisomatic boutons had multiple AZs.
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Figure 1 | Variability in CB1 content of axon terminals in the CA3 region of the hippocampus. (a) CB1 immunoﬂuorescent labelling is different in distinct
layers of the mouse hippocampus, and it is stronger in the distal CA3 (between white arrows) than in the proximal CA3 (between red arrows). In the distal
CA3, the stratum pyramidale is more intensely labelled than the strata oriens, lucidum and radiatum. (b) The boxed area in a is shown at a higher
magniﬁcation. (c) There is high variability in the CB1 content among individual boutons. Axon terminals with weak (red arrows), strong (white arrows) and
intermediate (orange arrows) CB1 immunoreactivity (CB1-IR) can be found in the stratum pyramidale of the distal CA3. (d,e) CB1 immunoﬂuorescent
reactions on sections obtained from a transcardially perfused mouse (d) and a rat (e). Individual boutons in stratum pyramidale have strong CB1-IR,
whereas axon terminals in strata oriens, lucidum and radiatum contain comparable levels of CB1-IR. Note that within each region, there is bouton-to-bouton
variability in the CB1 content. (f–h) Relative CB1-IR of individual boutons in different layers of the distal CA3 area of the hippocampus normalized to the
mean CB1 intensity of boutons in stratum radiatum. The CB1 content similarly changes between layers in slices derived from in vitro imaging experiments
(f), perfused mouse (g) and rat (h) sections. Randomized block design ANOVA was performed on the data sets before normalization, and signiﬁcant
difference between groups was found for the in vitro mouse (Po0.001, n¼6), perfused mice (Po0.001, n¼ 5) and perfused rat (Po0.001, n¼4) data.
Tukey post hoc test revealed a signiﬁcant difference between stratum pyramidale and stratum oriens (Po0.001, Po0.001 and P¼0.001), pyramidale
and lucidum (Po0.001, Po0.001 and P¼0.005) and pyramidale and radiatum (Po0.001, Po0.001 and Po0.001) for the in vitro slices, perfused
mice and perfused rat sections, respectively. str. ori., stratum oriens; str. pyr., stratum pyramidale; str. luc, stratum lucidum; str. rad., stratum radiatum.
Error bars in f–h represent s.d. Scale bars, 100mm (a), 50mm (b), 5mm (c–e). *denotes Po0.05.
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Our SDS-FRL experiments and EM 3D reconstructions extend
our LM immunoﬂuorescent results by showing that CB1 receptors
are located in the plasma membranes of axon terminals, and that
density and bouton surface differences primarily determine the
observed differences in the total CB1-IR of boutons.
Basket cell boutons contain more CB1 than those of DLI cells.
GABAergic INs expressing CCK and CB1 consist of distinct
subtypes that innervate distinct subcellular domains of post-
synaptic PCs and arborize mainly in distinct layers; basket, DLI,
perforant-path-associated and mossy ﬁber-associated cells have
been described20,27–30. In the present study, we focus on basket
and DLI cells, which mainly innervate the perisomatic and
dendritic region of PCs, respectively. The stronger CB1 labelling
in stratum pyramidale (Fig. 1) suggests that axon terminals of
basket cells contain more CB1 than those of DLI cells. Although
the axons of these cell types mainly arborize in distinct layers, a
remarkable amount of axon terminals can be found in other
layers29,31. For example, basket cells also have axons in strata
lucidum, proximal radiatum and oriens, whereas DLI cells also
arborize in stratum pyramidale. Thus, the observed layer-speciﬁc
differences cannot be directly used to infer cell type-speciﬁc
differences. Furthermore, within each hippocampal layer, we
detected large variability within the labelling intensity among
boutons; the mean coefﬁcient of variations (CVs) were 39%, 50%,
49% and 49% in strata pyramidale, oriens, lucidum and radiatum,
respectively. The origin of this variability cannot be determined
without examining individual identiﬁed cells.
To unequivocally identify the CB1 content of axon terminals of
distinct cell types, CCKþ INs were recorded with a biocytin- and
Fluo-5F-containing intracellular solution. Following in vitro
electrophysiological characterization and two-photon [Ca2þ ]
measurements, we immersion-ﬁxed the slices and immunola-
belled them for CB1 (Fig. 4). Qualitatively, cells with weakly and
strongly immunoreactive boutons were found in both IN
subtypes (Fig. 4a–d). When cells were analysed quantitatively in
the layers where their main axonal arbors were (basket: str.
pyramidale; DLI: str. radiatum), large heterogeneity was observed
in both basket and DLI cell populations, with CVs of 35% and
69%, respectively. The mean CB1-IR of basket cell axon terminals
was 91±32% of the average reactivity of the non-biocytin-ﬁlled
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Figure 2 | High-resolution immunogold localization of CB1 in the distal CA3 area of the mouse hippocampus. (a–d) Variability in the CB1 content of
boutons in distinct layers of the distal CA3 area. The CB1 labelling on the P-face of axon terminals (t) in stratum pyramidale (b) is more intense than in
strata oriens (a), lucidum (c) and radiatum (d). (e) Randomized block design ANOVA followed by Tukey post hoc test (n¼6) showed signiﬁcant difference
between strata pyramidale and lucidum (P¼0.019), between strata pyramidale and radiatum (Po0.001) and between strata oriens and radiatum
(P¼0.014). The labelling in all four layers was signiﬁcantly higher than the background (ANOVA: Po0.001; Tukey’s post hoc test: Po0.001;
n¼ 6 mice; 1.0±0.3 gold per mm2). Red diamonds indicate the mean±s.d. (f) Double-labelling experiments for CB1 (15 nm gold) and vesicular GABA
transporter (VGAT, 10 nm gold) reveal that the CB1-immunolabelled proﬁles are GABAergic axon terminals (t2), but not all VGAT-labelled terminals contain
CB1 (t1). (g) Background-subtracted density values for CB1 and VGAT of VGAT-immunopositive axon terminals are shown from two animals. Symbols
represent individual boutons. (h–k) The CB1 immunolabelling is abolished in CB1
 / mice. A perisomatic axon terminal is co-labelled with two
CB1 antibodies in a CB1
þ /þ mouse (t2 in h), while another is unlabelled (presumed parvalbumin-positive axon terminals, t1 in h). In CB1 / mice only
non-labelled proﬁles could be observed in the stratum pyramidale (t1 in i). A VGAT (10 nm gold) immunolabelled axon terminal is strongly CB1
immunopositive (15 nm gold, t2 in j) in a CB1
þ /þ mouse, but all VGAT-positive boutons are immunonegative in the CB1 / tissue (t1 in k). str. ori., stratum
oriens; str. pyr., stratum pyramidale; str. luc, stratum lucidum; str. rad., stratum radiatum; Rb, rabbit; Gp, guinea pig. All scale bars, 200nm. *denotes
Po0.05.
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Figure 3 | SDS-FRL localization of RIM1/2 and Cav2.2 subunit on CB1-immunopositive axon terminals in the distal CA3 area of the mouse
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axon terminals. (c) P-face sections of CB1-immunopositive (t2 in c) and negative (t1 in c) axon terminals are attached to an E-face somatic plasma
membrane. Both axon terminals contain a Rim1/2 positive AZ (blue). (d) Background-subtracted density values for CB1 and Rim1/2 measured in P-face
axon terminal sections attached to the E-face membrane of pyramidal cell somata. A total of 69.2% of axon terminal fragments were double negative, while
9.2% were only Rim1/2, 7.2% were only CB1-positive and the remaining 14.4% contained both Rim1/2 and CB1 labelling. (e) A P-face axon terminal
fragment attached to an E-face somatic membrane is co-labelled for CB1 and Cav2.2 subunit (t2), while another is unlabelled (t1). (f) Background-
subtracted densities for CB1 and Cav2.2 subunit within P-face axon terminal sections. The CB1-positive proﬁles were either Cav2.2 positive or negative, but
the majority (84.2%) of the Cav2.2 subunit-immunopositive proﬁles were CB1 positive. (g) Double-labelling experiments reveal that the P-face axon
terminal fragments attached to E-face somatic membranes are labelled for either Cav2.2 (t2) or Cav2.1 (t1) subunit. The AZ of an excitatory axon terminal
(t) contains large number of gold particles for both Cav2.2 and Cav2.1 subunits (orange, inset). (h) Background-subtracted density values for Cav2.2 and
Cav2.1 of P-face bouton fragments. (i–k) The Cav2.2 subunit immunolabelling is abolished in Cav2.2 / mice. Perisomatic axon terminals are labelled for
Cav2.2 in CCK-BAC/DsRedT3 (t in i) and Cav2.2þ /þ mice (t in j). In Cav2.2 / mice only non-labelled proﬁles were observed in stratum pyramidale.
Enlarged views of the boxed areas in a–c, e and g are shown on the right. str. ori., stratum oriens; str. luc, stratum lucidum; str. pyr., stratum pyramidale; Rb,
rabbit; Gp, guinea pig. Scale bars, 500nm (a–c,e,g); 100 nm, enlarged views of a–c and e; 200 nm, i–k and enlarged views and inset in g.
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boutons in the stratum pyramidale (for normalization see
Methods), whereas it was only 51±35% for DLI cells (Fig. 4e).
These results demonstrate that axon terminals of basket cells are
more strongly CB1 immunoreactive than those of DLI cells
(unpaired t-test, Po0.001, nbasket¼ 32, nDLI¼ 25), when mea-
sured in the layer where they mainly arborize. However, as
mentioned above, both cell types also possess axons outside their
main layers, the CB1-IR of which was the subject of our next
measurements. We selected bouton strings distant from the main
arbor and compared their reactivity with those that were in
stratum pyramidale for basket (Fig. 4f,g) and stratum radiatum
for DLI cells (Fig. 4h,i) and found no signiﬁcant difference in the
average CB1-IR between different layers (Fig. 4j; paired t-test,
basket: P¼ 0.11, n¼ 15; DLI: P¼ 0.31, n¼ 9).
Intrabouton [Ca2þ ] is smaller in basket than in DLI cells. Our
initial step towards assessing the function of presynaptic CB1 was
to measure AP-evoked, volume-averaged [Ca2þ ] transients in
individual CCKþ and CB1-immunoreactive boutons in acute
slices obtained from BAC-CCK-DsRed transgenic mice18,32.
Calcium imaging experiments were performed with a two-
photon laser scanning microscope. Cells were intracellularly
loaded with the calcium-sensitive dye Fluo-5F (100 mM) and
Alexa-594 (25 mM, Fig. 5a) for an initial 1 h equilibration period,
then bouton strings were selected and imaged in strata
pyramidale, radiatum, lucidum or oriens (Fig. 5c). Each AP
reliably evoked [Ca2þ ] transients in every bouton of the string,
the amplitude of which showed bouton-to-bouton variability
(basket: CV¼ 0.37±0.13, DLI: CV¼ 0.32±0.12). The peak
[Ca2þ ] transients also showed cell-to-cell variability within a
cell type (basket: CV¼ 0.31, DLI: CV¼ 0.38; Fig. 5e,f). DLI cells
had, on average 107% larger peak [Ca2þ ] transients compared
with basket cells (Fig. 5f; unpaired t-test, Po0.001, nbasket¼ 40,
nDLI¼ 31). In these experiments, basket cell boutons were
measured in stratum pyramidale, whereas those of DLI cells
were recorded in the dendritic layers. We also measured the
[Ca2þ ] in layers where the cells had only a small fraction of their
axons and found signiﬁcantly (paired t-test, P¼ 0.004, n¼ 8)
higher [Ca2þ ] for basket cells in the dendritic layers (Fig. 5g,h).
The [Ca2þ ] was also somewhat larger for DLI cells in the
dendritic layers (str. pyramidale G/Gmax¼ 0.184±0.053;
dendritic layers G/Gmax¼ 0.222±0.034, n¼ 4), but this did not
reach statistical signiﬁcance (Fig. 5g,h).
After the imaging experiments, the slices were immersion ﬁxed
and biocytin was visualized for post hoc determination of the cell
type based on the axonal arbor (Fig. 5b). The sections were also
immunolabelled for CB1 to assess the CB1-IR of the biocytin-ﬁlled
boutons of the imaged cells (Fig. 5d). Analysis of the peak [Ca2þ ]
and CB1-IR revealed no signiﬁcant correlation when both cell
types were analysed together (Fig. 5i, blue regression line,
Spearman’s correlation, r¼  0.18, P¼ 0.23, n¼ 47). When the
correlation analysis was performed on the two IN subtypes
separately, there was signiﬁcant positive correlation between peak
[Ca2þ ] and CB1-IR in the basket cell group (r¼ 0.55, P¼ 0.006,
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n¼ 24), but not for the DLI cells (r¼  0.017, P¼ 0.88, n¼ 23).
Analysis at the individual bouton level showed no correlation in
all analysed basket cells (Fig. 5j; r-values were: 0.02, 0.39, 0.30,
 0.26, 0.09, 0.46 and 0.21).
Cell type-dependent, CB1 content-independent effect of
AM251. Many factors could cause the smaller AP-evoked [Ca2þ ]
transients in basket cell boutons; the most obvious factors are (1)
larger bouton volumes, (2) higher endogenous Ca2þ buffering
and (3) smaller Ca2þ inﬂux in basket cells. Our 3D EM recon-
struction data showed that CCKþ boutons were 122% larger in
stratum pyramidale than in stratum radiatum (Supplementary
Fig. 4d). Different endogenous Ca2þ buffering is unlikely,
because the decay of the [Ca2þ ] transients did not differ between
basket and DLI cells (unpaired t-test, P¼ 0.72). The smaller
Ca2þ inﬂux in basket cell boutons can be a consequence of a
larger CB1-dependent suppression of N-type Ca2þ channel
function in these cells. Therefore, we examined how tonic,
endocannabinoid (eCB)-mediated regulation of presynaptic
[Ca2þ ] depends on the recorded cell type and on the CB1 content
of the boutons. First, we compared the [Ca2þ ] transients recor-
ded in control conditions and in slices pre-incubated with AM251
(1 mM) and found signiﬁcantly higher transients in basket
(Fig. 6a, unpaired t-test, Po0.001, ncontrol¼ 28, nAM251¼ 6), but
not in DLI (Fig. 6b, unpaired t-test, P¼ 0.48, ncontrol¼ 21,
nAM251¼ 8) cells. We also bath-applied AM251 (0.1 mM) to naive
slices after recording [Ca2þ ] transients in control conditions and
detected a signiﬁcant (paired t-test, P¼ 0.017) increase in basket
cells in stratum pyramidale (Fig. 6c,d,k), but not in the dendritic
layers (Fig. 6e,f,k). Bath application of 0.1mM AM251 caused no
signiﬁcant change in [Ca2þ ] transients of DLI cells in either the
stratum pyramidale (Fig. 6g,h,k) or the dendritic layers (Fig. 6i–
k). In addition, a higher AM251 concentration (2 mM) did not
change the amplitude of [Ca2þ ] in DLI cells when measured in
the dendritic layers (control G/Gmax¼ 0.25±0.08, AM251 G/
Gmax¼ 0.28±0.12, n¼ 5; effect of 0.1 mM: 12±12% versus effect
of 2 mM: 9±14%, P¼ 0.74, unpaired t-test).
These results reveal a hippocampal layer-speciﬁc effect of
AM251 on basket cell axon terminals. Furthermore, we
performed ‘double recordings’ on bouton strings of individual
cells that located in distinct layers and tested the effect of AM251
on the peak [Ca2þ ]. Similarly to individual cell recordings, the
effect of AM251 was larger in stratum pyramidale (77±57%)
than in dendritic layers (22±26%) when analysed at the level of
individual boutons of a given cell (Supplementary Fig. 6a–d) or
for single cells (Supplementary Fig. 6e).
Post hoc identiﬁcation of the recorded cells and quantitative
determination of their CB1-IR allowed us to reveal the lack of
signiﬁcant correlation between the effect of AM251 and the initial
[Ca2þ ] (Fig. 6l, Spearman’s r¼  0.48, P¼ 0.062, n¼ 16) or the
CB1-IR (Fig. 6m, r¼ 0.11, P¼ 0.7, n¼ 15) when all cells were
analysed together (blue regression lines). Next, we investigated
the correlations between AM251 effect and initial [Ca2þ ] or CB1-
IR in basket cells only, the cell population where signiﬁcant
AM251 effect was observed, but we still failed to reveal any
signiﬁcant correlation (Fig. 6l, r¼  0.12, P¼ 0.77, n¼ 9;
Fig. 6m, r¼  0.43, P¼ 0.29, n¼ 8, black regression lines).
Finally, the measurements of [Ca2þ ], AM251 effects and CB1-IR
in individual axon terminals allowed us to investigate the
correlations between these parameters at the level of individual
boutons within single cells. The AM251 effect showed a negative
signiﬁcant correlation with [Ca2þ ] in 5 out of 9 cells (Fig. 6n, r-
values were  0.81,  0.82,  0.82, 0.14,  0.57,  0.98,  0.91,
 0.21 and  0.23). However, when the effect of AM251 was
examined as a function of CB1-IR, we found no signiﬁcant
correlations in our analysed 7 cells (Fig. 6o, r-values were 0.079,
 0.29,  0.10, 0.77, 0.43,  0.38 and  0.43).
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(i) The amplitude of [Ca2þ ] transients is independent of the CB1 immunoreactivity of the cells when all cells are analysed together. When basket and DLI
cells are analysed separately, signiﬁcant positive correlation (Spearman correlation r¼0.55, P¼0.006) was found in baskets, but not in DLI cells. (j) No
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Cell type- and CB1-content-independent effect of CB1 agonist.
Since AM251 did not have a signiﬁcant effect on [Ca2þ ] tran-
sients in DLI cells, in our ﬁnal sets of experiments we tested how
the CB1 agonist WIN55212-2 (WIN) affects [Ca2þ ] transients,
and analysed the correlation between the drug effect and the CB1
content of the boutons (Fig. 7). The application of 100 nM WIN
signiﬁcantly decreased the AP-evoked [Ca2þ ] transients
(Fig. 7a,b) in DLI cells. This effect was concentration dependent;
10 nM caused 16±12% (Fig. 7e, paired t-test, P¼ 0.16, n¼ 4),
whereas 100 nM resulted in 44±18% (Fig. 7b, paired t-test,
P¼ 0.027, n¼ 5) reduction in DLI cells and was reversed by
AM251 (Fig. 7g,h). We also performed the same analysis on
basket cells and found a similar concentration-dependent inhi-
bition (10 nM: 31±24%, P¼ 0.13, n¼ 3, paired t-test; 100 nM:
48±9%, P¼ 0.003, n¼ 7, paired t-test; Fig. 7b,e). The effect of
WIN did not show a correlation with the CB1 content of the
boutons either when both cell types were analysed together
(Fig. 7c, blue regression line, Spearman’s r¼  0.22, P¼ 0.48,
n¼ 12; Fig. 7f, blue regression line, r¼  0.61, P¼ 0.15, n¼ 7)
or when only basket cells were evaluated (Fig. 7c, black regression
line, r¼  0.46, P¼ 0.29, n¼ 7). Finally, we also revealed a lack
of correlation between CB1-IR and the carbachol-induced33
increased eCB-evoked reduction of [Ca2þ ] transients (Fig. 7i,
Spearman’s r¼  0.18, P¼ 0.7, n¼ 7).
In summary, our experiments clearly show the lack of
correlation between the total CB1 content of boutons and the
degree of CB1-mediated control of presynaptic [Ca2þ ] transients.
Discussion
In the present study, we report the ﬁrst investigation of the
‘number–function’ relationship for a metabotropic receptor in a
small subcellular compartment of a central neuron; CB1 on axon
terminals of CCK-expressing hippocampal GABAergic INs. To
determine the ‘number’ of CB1, we quantiﬁed LM immunoﬂuor-
escent labelling using confocal microscopy. EM SDS-FRL was also
used as an independent method for providing a quantitative
comparison of the CB1 density of boutons in distinct layers.
Currently, SDS-FRL is widely accepted as the method of choice
for quantitative, high-resolution localization of plasma membrane
proteins. This method bestows unprecedented sensitivity and
high resolution34. Unfortunately, a major weakness of SDS-FRL is
that it cannot be used for analysing the molecular content of
physiologically characterized individual cells due to random
fracturing of the tissue. SDS-FRL experiments revealed that axon
terminals contain a signiﬁcantly higher (26% in mice, 31% in rats)
density of CB1 in stratum pyramidale than in the stratum
radiatum. This difference in density is smaller than that (71% in
postﬁxed slices; 49% in perfused mice; 83% in perfused rats)
found in the total CB1 content of axon terminals in strata
pyramidale and radiatum. Performing EM 3D reconstruction
from serial ultrathin sections, we found that the surface area of
CCKþ boutons was 113% higher in stratum pyramidale than in
the stratum radiatum. This ﬁnding is consistent with recent
studies showing that axon terminals of Schaffer collateral-
associated INs are smaller than those of basket cells in the CA1
area25,28. When we measured the total CB1 content of identiﬁed
basket and DLI axon terminals, differences in mean CB1-IR
between these subtypes were revealed. This is again consistent
with the ﬁnding of Dudok et al.25 in CA1 using LM
immunoﬂuorescent labelling and super-resolution analysis. Our
results also showed a robust within-cell type variability in CB1-IR
of the recorded and analysed basket (CV¼ 0.35) and DLI
(CV¼ 0.69) cells. If the CB1 content of a presynaptic bouton
depends on the identity of postsynaptic target cell, then a
potential reason for the higher variability in DLI cells might be
that these INs differentially innervate distinct types of PCs
projecting to speciﬁc brain regions35, or they may form synapses
with a larger fraction of GABAergic INs as postsynaptic targets28.
To estimate the ‘function’ of the CB1 activation, two-photon
Ca2þ imaging was performed in acute hippocampal slices at the
level of individual axon terminals of CCKþ basket and DLI cells.
A previous study from our laboratories provided a quantitative
understanding of how the presynaptic [Ca2þ ] affects release at
these GABAergic axon terminals18 and showed that tonic CB1
activation exerts its effect mainly through the reduction of N-type
Ca2þ channel function. Thus, knowing the relationship between
[Ca2þ ] and release, and that CB1 only affects Ca2þ inﬂux, we
used presynaptic [Ca2þ ] transients as an approximation of
presynaptic release. Our experiments revealed a 107% larger
presynaptic [Ca2þ ] transient in DLI compared with basket cell
axon terminals in control conditions. This difference is partly due
to the larger CB1-mediated reduction of [Ca2þ ] in basket cells
(estimated by the effect of AM251). However, when the
amplitudes of [Ca2þ ] are compared in the presence of AM251
between basket and DLI cells, an B45% larger transient is still
observed (data pooled from the steady-state and wash-in
experiments, Fig. 6a,b,k). This can be explained by more
pronounced Ca2þ buffering36, a larger bouton volume28 or a
smaller Ca2þ inﬂux in basket cells. Although, we have not
directly tested the Ca2þ buffering capacity in the axons of the
two different cell types, the similar decay kinetic of the [Ca2þ ]
transients is inconsistent with large differences in buffering36. It is
worth noting that some of the DLI cells may contain calbindin-
D28k28,29,37, a calcium-binding protein that should increase the
buffer capacity of those DLI cells. However, a larger endogenous
buffering would reduce, rather than increase the measured
[Ca2þ ] transient in DLI cells. Our EM 3D reconstructions
revealed that the mean volume of boutons in stratum pyramidale
wasB120% larger than that in stratum radiatum. Calculating the
total ﬂuxed Ca2þ from the [Ca2þ ] and bouton volume indicated
that B65% more Ca2þ enters the terminals of basket cells upon
an AP. This value is very similar to the ratio (1.5) of total AZ
Figure 6 | The CB1 antagonist AM251 signiﬁcantly increases [Ca
2þ ] transients in axon terminals of basket, but not those of DLI cells in the CA3 area.
(a,b) The amplitude of [Ca2þ ] transients is larger in basket (a), but not in DLI cells (b) when [Ca2þ ] measurements were performed in 1 mM AM251 pre-
incubated slices. (c–j) Effect of 100 nM AM251 on individual boutons in basket (c-f) and DLI cells (g–j) in stratum pyramidale (c,d,g,h) and in dendritic
layers (e,f,i,j). The imaged boutons are labelled on the confocal Z-stack maximum intensity projection image (red, biocytin; green, CB1), and corresponding
[Ca2þ ] transients are shown before (left traces) and after (right traces) AM251 application (c,e,g,i). Amplitude values of [Ca2þ ] transients recorded from
individual boutons in control condition and after AM251 application are shown in d,f,h and j. AM251 signiﬁcantly increases [Ca2þ ] transients in strata
pyramidale (d, paired t-test, P¼0.005, n¼ 7 boutons) and lucidum (f, paired t-test, P¼0.012, n¼ 7 boutons) in basket cells. (k) AM251 effect on the
amplitude of [Ca2þ ] transients at individual cells in strata pyramidale and lucidum/radiatum. Every symbol represents an individual cell. (l–m) The AM251
effect does not depend on either the peak [Ca2þ ] (l) or the relative CB1 content of the boutons (m). Measurements were performed in stratum pyramidale
(circles) and radiatum/lucidum (triangles) for basket (black) and DLI (red) cells, respectively. When the correlation was analysed only for basket cells, no
signiﬁcant effect was seen. (n–o) Correlation analysis at the level of individual boutons revealed signiﬁcant correlation between AM251 effect and G/Gmax
in ﬁve out of nine cells (n). Each cell is colour coded and open symbols represent individual boutons. There was no correlation between AM251 effect and
CB1 immunoreactivity in all analysed (n¼ 7) cells (o). Error bars in a,b,d,f,h,j and k represent s.d. Scale bars, 5 mm (c,e,g,i). *denotes Po0.05.
ARTICLE NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7557
8 NATURE COMMUNICATIONS | 6:6557 | DOI: 10.1038/ncomms7557 | www.nature.com/naturecommunications
& 2015 Macmillan Publishers Limited. All rights reserved.
Basket
Basket
Basket
str. pyr.
DLI
str. pyr.
DLI
Basket
Basket—boutons
Basket —boutons
DLI
DLI Basket
luc/rad.
DLI
luc/rad.
0.4
0.3
0.2
0.1
0.0
G
/G
m
a
x
0.4
0.3
0.2
0.1
0.0
0.4
0.3
0.2
0.1
0.0
Boutons
Boutons
Boutons
DLI #2 - str. rad.
DLI #1 - str. pyr.
Basket #2 - str. luc.
Basket #1 - str. pyr.
9
12
10
8
5
7
7
2
5
50 ms
0.1
G/Gmax
50 ms
0.1
G/Gmax
50 ms
0.1
G/Gmax
50 ms
0.1
G/Gmax
Boutons
2.5
2.0
1.5
1.0
0.0
0.0 0.1 0.2 0.3
0.5
G
/G
m
a
x
G
/G
m
a
x
G/Gmax
G/Gmax
0.0
0.0 0.1 0.2
CB1-IR (a.u.)
0 500 1,000
0.5 1.0
Relative CB1-IR
0.4
0.3
0.2
0.1
0.0
G
/G
m
a
x
0.4
11
6
4
2
0
0.3
0.2
0.1
0.0
G
/G
m
a
x
0.4
0.3
0.2
0.1
0.0
G
/G
m
a
x
AM
25
1 
ef
fe
ct
2.5
2.0
1.5
1.0
0.0
0.5
AM
25
1 
ef
fe
ct
AM
25
1 
ef
fe
ct
11
4
2
0
AM
25
1 
ef
fe
ct
AC
SF
AM
25
1
AC
SF
AM
25
1
CT
R
AM
25
1
CT
R
AM
25
1
CT
R
AM
25
1
CT
R
AM
25
1
CT
R
AM
25
1
CT
R
AM
25
1
CT
R
AM
25
1
CT
R
AM
25
1
0.3
0.2
0.1
0.0
G
/G
m
a
x
*
*
*
*
NATURE COMMUNICATIONS | DOI: 10.1038/ncomms7557 ARTICLE
NATURE COMMUNICATIONS | 6:6557 | DOI: 10.1038/ncomms7557 | www.nature.com/naturecommunications 9
& 2015 Macmillan Publishers Limited. All rights reserved.
areas in boutons in strata pyramidale and radiatum, indicating a
similar Ca2þ channel density in the AZs of these two different
cell types.
Our results demonstrated that basket cell axon terminals
contain more CB1, have smaller initial [Ca2þ ] and a larger tonic
eCB-mediated reduction of [Ca2þ ] than DLI cells. However, it
was surprising to see the lack of correlation between CB1-IR and
the effect of drugs that modulate CB1 function (AM251,
WIN55212-2 and carbachol). The two most likely explanations
of these results are as follows.
(1) Tonic eCB-mediated reduction of [Ca2þ ] might be
primarily determined by the concentration of the ligand, and
not the number of receptors. Our results would then predict a
higher eCB concentration in stratum pyramidale compared with
the dendritic layers. The eCB causing this effect is either 2-
arachidonoyl glycerol (2-AG) or anandamide38–40. The 2-AG-
synthesizing enzyme (diacylglycerol lipase-a) has been found
mainly in spines of PCs, resulting in a higher concentration in
dendritic layers compared with stratum pyramidale41. This
regional distribution of diacylglycerol lipase-a would predict an
opposite 2-AG concentration gradient: high in the dendritic
layers and low in stratum pyramidale. The concentration of 2-
AG, however, does not only depend on its synthesizing enzyme,
but also its degrading pathway. The hydrolyzing enzyme of 2-AG
(monoacylglycerol lipase-a) is also concentrated in the dendritic
layers of the hippocampus, where it is located mainly in
glutamatergic axons42. In addition, monoacylglycerol lipase-a
was shown to be present in astrocytes43, which has less processes
in stratum pyramidale compared with the dendritic layers44,
indicating that glia cells could also play a role in the degradation
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Figure 7 | Activation of the CB1 signiﬁcantly decreases [Ca
2þ ] transients in axon terminals of basket and DLI cells in the CA3 area. (a,b,d,e) Effect of
the CB1 agonist WIN 55212-2 (10 and 100nM) on [Ca
2þ ] transients in individual basket (in stratum pyramidale) and DLI cells (in dendritic layers).
The effect of 10 nM did not reach signiﬁcance, but that of 100nM was signiﬁcant. (c,f) The WIN 55212-2 effect does not depend on the CB1 content of
cells when analysis were either performed in all recorded cell (blue regression lines in c and f) or only for basket cells (black regression line in c). (g,h) The
effect of 100 nM WIN 55212-2 can be reversed by the CB1 antagonist AM251 (1 mM). (i) The effect of 5 mM carbachol did not depend on the CB1
immunoreactivity of the cells. Error bars in b,e and h represent s.d. All scales for a,d and g are shown in d. *denotes Po0.05.
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of 2-AG in the dendritic layers. However, due to the highly
lipophilic nature of 2-AG, it is very unlikely that it would
effectively diffuse hundreds of microns from the dendritic layers
to the stratum pyramidale. The potential role of anandamide is
even more uncertain: the synthesizing enzyme (N-acyl
phosphatidylethanolamine-speciﬁc phospholipase D) is located
on presynaptic glutamatergic axons resulting in a high density in
the dendritic layers45, whereas one of its degrading enzymes (fatty
acid amide hydrolase) is present at high concentrations in
stratum pyramidale42.
(2) Another possible explanation is a more efﬁcient coupling of
CB1 to N-type Ca2þ channels in basket cells. Factors that
determine the ‘coupling efﬁciency’ are largely unknown, but a
potential way of conceptualizing it might be that the ‘functionally
relevant’ CB1s could have a special location within the boutons.
Where could these ‘special’, ‘functionally relevant’ receptors be?
Here we provided direct evidence for molecular-scale colocaliza-
tion of the N-type Ca2þ channels with CB1 probably within the
AZ. Our SDS-FRL reactions clearly demonstrated the presence of
CB1 in AZs in addition to peri- and extrasynaptic locations, in
agreement with the results of a previous study applying
postembedding immunogold localization24. Our data also
revealed heterogeneity in the CB1 content of AZs; some Rim1/
2-positive AZs were strongly (Fig. 3b; Supplementary Fig. 2b)
labelled, whereas some were apparently immunonegative (Fig. 3c;
Supplementary Fig. 2c). This raises the possibility that the degree
of tonic eCB-mediated modulation of presynaptic [Ca2þ ], and
consequently neurotransmitter release, might depend on the
amount of CB1 in the presynaptic AZ close (tens of nanometres)
to N-type Ca2þ channels. The different amounts of CB1 in AZs
could be achieved by the rapid diffusion of receptors in and out of
synapses as shown with single-molecule tracking after agonist-
induced desensitization46.
The above mentioned two possibilities are of course not
mutually exclusive; if CB1s in the AZs have a special role, there
could still be differences in eCB concentrations in distinct
hippocampal layers and synapses.
Furthermore, we cannot rule out the possibility that phasic
eCB-mediated regulation of release (for example, during
depolarization-induced suppression of inhibition or inhibitory
long-term depression) depends on the total bouton CB1 content.
A scenario might be envisaged in which, similar to the pure
synaptic versus synaptic plus extrasynaptic activation of post-
synaptic AMPA and GABAA receptors, the population of
presynaptic CB1 that mediates the regulation of release might
change as a function of postsynaptic activity.
To directly test these models, a novel quantitative localization
approach needs to be developed, as neither of the widely used
preembedding immunogold or immunoﬂuorescent techniques
are capable of visualizing synaptic receptors without antigen
retrieval, and SDS-FRL cannot be used on functionally char-
acterized axon terminals.
Methods
Slice preparation. Acute 250-mm-thick horizontal hippocampal slices were cut
from 19.3±2.5-day-old (P15–P27) transgenic mice (n¼ 128) from both sexes
expressing DsRed ﬂuorescent protein under the control of the cholechystokinin
promoter (CCK-BAC/DsRedT3mouse line)32. Animals were handled in accordance
with the Hungarian Act of Animal Care and Experimentation (1998, XXVIII,
section 243/1998) and with the ethical guidelines of the Institute of Experimental
Medicine Protection of Research Subjects Committee. Mice were anaesthetized
with isoﬂurane, then the brains were quickly removed and placed into an ice-cold
solution containing (in mM): sucrose, 204.5; KCl, 2.5; NaHCO3, 26; CaCl2, 0.5;
MgCl2, 5; NaH2PO4, 1.25; glucose, 10; bubbled with 95% O2 and 5% CO2.
Hippocampal slices were cut using a Leica vibratome (Leica VT1200S; Leica
Microsystems), then incubated in an interface-type holding chamber ﬁlled with
36 C ACSF containing (in mM): NaCl, 126; KCl, 2.5; NaHCO3, 26; CaCl2, 2;
MgCl2, 2; NaH2PO4, 1.25; glucose, 10; saturated with 95% O2 and 5% CO2.
Recordings were carried out using the same ACSF solution at 22 C. Slices were
kept up to 6 h in the holding chamber prior to use.
Electrophysiological recordings and two-photon imaging. Two-photon imaging
experiments were performed with a Femto2D (Femtonics Ltd.) laser scanning
microscope, using a MaiTai femtosecond pulsing laser (Spectra Physics) tuned to
810 nm. Cells were visualized using oblique infrared illumination and a water
immersion lens ( 25, 1.05 numerical apperture, Olympus or  25, 1.1 numerical
apperture, Nikon). CCK-containing INs in the CA3 region of hippocampus
expressing DsRed were identiﬁed based on their red ﬂuorescence. Whole-cell
recordings were conducted in current-clamp mode using a MultiClamp 700A
ampliﬁer (Molecular Devices). Electrophysiological traces were ﬁltered at 3 kHz
and digitized online at 20 kHz. Patch pipettes were pulled (Zeitz Universal Puller;
Zeitz-Instrumente Vertriebs) from thin-walled borosilicate glass capillaries with an
inner ﬁlament (1.5mm outer diameter, 1.17mm inner diameter; Harvard Appa-
ratus). Pipette resistance was 5–7MO. The intracellular solution contained (in
mM): K-gluconate, 130; KCl, 5; MgCl2, 2; creatine phosphate, 10; HEPES, 10;
Na2ATP, 2; Na2GTP, 1; biocytin, 7, pH was adjusted to 7.3; the osmolarity was
280–290mOsm. Before the recordings, 100 mM Fluo-5F (KDB2.3 mM, Molecular
Probes) and 25 mM Alexa Fluor 594 (A594, Molecular Probes) were added to each
aliquot of intracellular solution. INs were held between  60 and  65mV with a
maximum of  200 pA d.c. current injection. Pairs of APs at 10Hz were evoked
every 30 s with 1.5–2-ms-long depolarizing (1–1.2 nA) current pulses. Two-photon
imaging and electrophysiological data were analysed with a Matlab-based software
(MES, Femtonics Ltd). Only the ﬁrst AP-evoked [Ca2þ ] transients were analysed
in this study. Drugs were applied using a recirculation system with a peristaltic
pump, where the total volume wasB6ml and the solutions were equilibrated with
95% O2 and 5% CO2. AM251 (Tocris) was dissolved in dimethylsulphoxide
(DMSO) to reach a 10-mM stock solution. Experiments were carried out to show
that DMSO does not affect the amplitude of [Ca2þ ] transients at 0.1% ﬁnal bath
concentration. The DMSO concentration was 0.01% or 0.001% during AM251 pre-
incubation (1 mM) and bath application (0.1 mM) experiments, respectively. WIN
55212-2 was dissolved in 0.1M HCl solution to reach 20mM concentration. The
5mM HCl solution, which is 1,000-fold higher than the highest concentration of
HCl in the WIN solution used in the experiments, did not change the pH of the
ACSF. Carbachol (20mM stock) was dissolved in distilled water. All drugs were
purchased from Sigma unless indicated otherwise.
For detailed description of the imaging experiments and calculation of G/Gmax,
see Holderith et al.26 and Szabo et al.18 Brieﬂy, after an hour of loading period, a 20-
min ‘control’ scanning period was performed during whichB10–15 boutons at 30–
60mm depth were scanned (500-ms-long line-scans were applied with a 1-kHz
sampling rate) each twice with a 30-s interval. The same 20-min scanning period was
repeated on the same boutons after a 15- or 30-min drug equilibration period. The
amplitude of [Ca2þ ] transients went through a gradual decline during the B2-h
imaging session in ACSF; therefore all drug effects were normalized to their
corresponding reduction in ACSF. Control recordings in ACSF were intermingled
with the drug experiments, and the reduction in the peak amplitude of [Ca2þ ] in
ACSF was calculated for each block/series of pharmacology experiments (6–8 weeks
per block). The amplitudes in ACSF were reduced to 92.9±15% (n¼ 11, ﬁrst set of
experiments) and 88.9±18% (n¼ 6, second set of experiments) after 15min, and
87.7±14.3% (n¼ 4) after 30min. In some experiments the scanning period was
lengthened to 35–55min when two or three hippocampal layers were imaged. For
those experiments, we performed ACSF controls at time points of 15, 35 and 55min,
and the amplitudes were reduced to 91.5±7.5% (n¼ 3), 82.2±11.9% (n¼ 3) and
72.7±4.8% (n¼ 3) of control, respectively. Throughout the ﬁgures, the [Ca2þ ]
transient traces are not modiﬁed, but the summary data are normalized to these
reductions. The effect of drugs for individual boutons/cells was calculated by dividing
the peak amplitude value of [Ca2þ ] transients (for a bouton: measured from the
average of two individual traces; for cells: measured from the average of all individual
traces of boutons in that cell) in the presence of the drug with that in control
condition (peak measured within a time window of 4–11ms after AP initiation), and
then this ratio was normalized to the decline observed in ACSF (see above). The
[Ca2þ ] transients of individual cells did not depend on the somatic AP full-width at
half-maximal amplitude, AP peak amplitude, the access resistance, the holding
potential (between  54 and  68mV), the holding current (from 0 to  200 pA)
or the ‘baseline’ green ﬂuorescence measured after 60min of dye loading
(Supplementary Fig. 7a–f). In addition, no correlation was found between the
distance of the imaged bouton string from the soma and the amplitude or the decay
of [Ca2þ ] transients, or the amplitude of the Alexa Fluor 594 ﬂuorescence
(Supplementary Fig. 7g–i).
Fluorescent immunohistochemistry. After the imaging experiments, slices were
placed in a ﬁxative containing 4% paraformaldehyde (PFA) and 0.2% picric acid in
0.1M phosphate buffer (PB; pH¼ 7.4) at 4 C for412 h, and then were washed in
PB several times, embedded in agarose (2%) and re-sectioned at 60–80 mm thick-
ness. Sections were washed with PB and blocked in normal goat serum (NGS; 10%)
made up in Tris-buffered saline (TBS, pH¼ 7.4). CB1 was visualized using a rabbit
anti-CB1 antibody (Cayman Chemical Company, Cat. No. 10006590), which was
raised against amino acids (aa.) 461–472 of the human CB1 receptor, diluted in
1:1,000 in TBS containing 0.1% Triton. For some immunoreactions on perfusion-
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ﬁxed tissue sections, a guinea pig anti-CB1 (1:500; Frontier Institute Co. Ltd, Cat.
No. CB1-GP-Af530) antibody was also used. The epitope of this antibody (aa. 443–
473 of the mouse CB1 protein)47 overlaps with that of the rabbit antibody. Identical
labelling of the two CB1 antibodies was conﬁrmed by double-labelling experiments.
The speciﬁcity of the CB1 immunoreactions was conﬁrmed using CB1 / and
CB1þ /þ mice48. After several washes in TBS, Alexa488-conjugated goat anti-
rabbit immunoglobulin (Ig)G (1:500; Life Technologies) or Cy3-conjugated donkey
anti-guinea pig IgG (1:1,000; Jackson ImmunoResearch Laboratories) was used to
visualize the CB1 immunoreaction, while Cy3-conjugated streptavidin (1:500;
Jackson ImmunoResearch Laboratories) was used to visualize the biocytin. Sections
were then mounted on slides in Vectashield (Vector Laboratories). Images were
acquired using an Olympus FV1000 confocal microscope with either a  10,  20
or a  60 objective. Cells were identiﬁed as basket, mossy ﬁber-associated, DLI and
perforant-path-associated cells based on their axonal arborization20,27–30. Mossy
ﬁber-associated and perforant-path-associated cells were discarded from the
analysis because of the low number of recordings. Only CB1-immunopositive cells
were included in the study.
Evaluating the CB1 content of boutons in hippocampal layers. Immunohisto-
chemical reaction for CB1 was performed on in vitro slices that were immersion
ﬁxed and re-sectioned after the recording and imaging session and on sections
from perfusion-ﬁxed male rat (P30-36, 34.5±2.5-day-old animals, n¼ 4) and
CCK-BAC/DsRedT3 male mouse (P20-25, 23.2±2-day-old animals, n¼ 5) brains.
Confocal Z-image stacks (with the same laser power, photomultiplier settings,
pinhole size and dwell time) were acquired between 5 and 10 mm depth from the
tissue surface with a 0.5-mm step size in strata pyramidale, lucidum, radiatum and
oriens in the distal CA3 region. In each Z-image stack, 32–40 CB1-positive boutons
were chosen randomly at single confocal layers and circular/elliptic regions of
interest (ROIs) were placed over them (usually 8–10 CB1-positive boutons and two
background ROIs in four optical layers) using the FV1000-ASW1.6 software
(Olympus Corporation). Special care was taken to select boutons in focus, and
boutons were discarded if additional ﬂuorescence coming from neighbouring
boutons affected the measurement (Supplementary Fig. 8). The integral of the CB1
signal was measured in every ROI, including CB1-positive boutons and sur-
rounding background areas. The background-subtracted CB1 intensity of the
boutons was then calculated. To compare different hippocampal regions within a
slice, mean CB1 intensity values of strata pyramidale, lucidum and oriens were
normalized to those obtained in the stratum radiatum.
Evaluating the CB1 content of individual cells. The relative CB1-IR (obtained
with the rabbit anti-CB1 antibody) of whole-cell recorded GABAergic INs was
calculated as follows: confocal Z-image stacks were acquired in those hippocampal
layers where the Ca2þ imaging took place (usually the same region where the main
axonal arbor of a cell was) in addition to stratum pyramidale. The image stacks
were acquired in the same way as described above. Biocytin-ﬁlled boutons (18±6.8
boutons; not the ones that were in vitro Ca2þ imaged) were identiﬁed in the
imaged hippocampal layer, and 32 biocytin-unlabelled boutons were randomly
selected in the stratum pyramidale. CB1 intensity was measured using ROIs
placed over boutons, the average of CB1 intensity integrals were calculated for
biocytin-containing and -lacking boutons. The strength of the CB1-IR of a cell was
normalized to the average CB1 reactivity of randomly chosen boutons in the
stratum pyramidale. CB1-IR values used for individual bouton analysis were not
normalized (Figs 5j and 6o).
SDS-digested freeze-fracture replica-labelling (SDS-FRL). Male Wistar rats
(P30–P46, 40.8±6.6, n¼ 5), CCK-BAC/DsRedT3 mice (P19–P25, 22.9±2.5, n¼ 2
female, n¼ 7 male), CB1þ /þ (P18, P26, n¼ 2 female) CB1 / (P18, n¼ 2
female)48, Cav2.2þ /þ (P18, n¼ 1) and Cav2.2 / (9 months old, n¼ 1)49 mice
were deeply anaesthetized and transcardially perfused with an ice-cold ﬁxative
containing 2% PFA and 15v/v% picric acid in 0.1M PB for 15min. Coronal
sections of 80mm thickness were cut from the forebrain with a vibratome and were
cryoprotected in 30% glycerol. Replicas were prepared as described previously50,51.
Brieﬂy, small blocks from the CA3 area were frozen in a high-pressure freezing
machine (HPM100, Leica Microsystems) and fractured at  135 C in a freeze-
fracture machine (BAF060, Leica Microsystems). The fractured tissue surfaces were
coated with thin layers of carbon (5 nm), platinum (2 nm) and carbon (20 nm).
Tissue debris was digested from the replicas in a solution containing 2.5% SDS and
20% sucrose in TBS at 80 C overnight. Following several washes in TBS containing
0.05% bovine serum albumin (BSA), replicas were blocked in TBS containing 2.5–
5% BSA for 1 h, then incubated overnight in the same blocking solution containing
primary antibodies. The following primary antibodies were used: rabbit anti-CB1
antibody (1:500, Cayman Chemical, Cat. No. 10006590), guinea pig anti-CB1
(1:100, Frontier Institute Co. Ltd, Cat. No. CB1-GP-Af530; used for quantiﬁcation),
guinea pig anti-VGAT (1:2,000, Synaptic Systems, Cat. No. 131 004), rabbit anti-
Rim1/2 (1:2,000; Synaptic Systems, Cat. No. 140 203), rabbit anti-Cav2.2 (1:400,
Synaptic Systems, Cat. No. 152 303), guinea pig anti-Cav2.1 (1:100, Frontier
Institute Co. Ltd, Cat. No. VDCCa1A-GP-Af810) and rabbit anti-Cav2.1 (1:500,
Synaptic System, Cat. No. 152 203). Replicas were then incubated for 2 h in TBS
containing 5% BSA and goat anti-rabbit IgGs coupled to 5, 10 or 15 nm gold
particles (1:100; British Biocell International Ltd) or to 6 nm gold particles (1:30;
AURION Immuno Gold Reagents & Accessories) and goat anti-guinea pig IgGs
coupled to 10 or 15 nm gold particles (1:50 or 1:100; British Biocell or 1:30;
AURION). Finally, replicas were rinsed in TBS and in distilled water before being
picked up on copper parallel-bar grids coated with pioloform. Specimens were
analysed with a transmission EM (JEM-1011, JEOL Ltd). All antibodies used in this
study recognized intracellular epitopes and consequently were visualized on the
P-face. The speciﬁcity of the CB1 immunolabelling was tested on replicas in
CB1 / and CB1þ /þ mice. In single-labelling experiments, immunogold particles
for CB1 were abolished from axon terminals in every layer of the CA3 in the
CB1 / tissue (n¼ 2 mice). Double-labelling reactions for CB1 using two different
anti-CB1 antibodies resulted in double-labelled axon terminals in CB1þ /þ mice
(Fig. 2h), while on replicas from CB1 / mice no labelled proﬁles were
found (Fig. 2i). Furthermore, CB1 labelling showed extensive colocalization with
VIAAT in CB1þ /þ mice (31 CB1-positive out of 60 VIAAT-positive boutons;
Fig. 2j), but in CB1 / mice all VIAAT terminals (0 out of 53) were
immunonegative for CB1 (Fig. 2k). For quantitative analysis, electron micrographs
of presynaptic axon terminals labelled for CB1 were taken (n¼ 552 boutons in 4
rats, n¼ 705 boutons in 6 CCK-BAC/DsRedT3 mice) from strata oriens,
pyramidale, lucidum and radiatum of the distal CA3 area with a Cantega G2
camera (Olympus Soft Imaging Solutions GmbH) at  10.000–25.000
magniﬁcations. The nonspeciﬁc background labelling was measured on E-face
structures surrounding the measured P-faces. Gold particle counting and area
measurements were performed with iTEM software (Olympus Soft Imaging
Solutions). The speciﬁcity of the Cav2.2 immunolabelling was conﬁrmed using
tissue derived from Cav2.2 / mice, where immunogold particles for Cav2.2 were
mostly abolished from P-face sections of axon terminals attached to somatic E-face
membranes (0–3 gold particles in 189 proﬁles, n¼ 2 animals), whereas in
Cav2.2þ /þ mice these structures were strongly labelled for Cav2.2 (0–15 gold
particles in 301 proﬁles, n¼ 2 animals). In addition, in Cav2.2þ /þ mice, excitatory
axon terminals (identiﬁed based on the presence of an AZ facing a postsynaptic
density on E-faces) contained stronger Cav2.2 labelling (0–7 gold particles in 27
proﬁles), compared with Cav2.2 / mice (0–3 gold particles in 51 proﬁles). To
quantify the CB1, Rim1/2, Cav2.2 and Cav2.1 subunit densities on axon terminals
(for Fig. 3d,f,h; Supplementary Figs 2f and 3b,e,i), electron micrographs of PC
somatic E-face membranes with attached P-face axon terminal fragments were
taken at  10,000–25,000 magniﬁcation from stratum pyramidale. These attached
P-face proﬁles showed large variability in sizes. We have restricted our analysis to
those proﬁles that had an area40.1 ando0.21 mm2, corresponding to the range of
AZ sizes obtained from our EM 3D reconstructions. The gold particle densities
were then calculated in these P-face membranes without assuming that the entire
membrane is an AZ. The AZs of CB1-positive boutons do not contain an elevated
density of intra-membrane particles, therefore their delineation based on
morphological criteria is not possible. Molecules that are conﬁned to the AZ should
therefore be used in identifying AZs. Here we used Rim1/2 immunolabelling for
this purpose and delineated potential AZs in our ﬁgures for illustrative purposes
only. However, we refrain from performing quantitative analysis of, for example,
CB1-IR in AZs, due to uncertainties in determining the borders of the AZs.
The colocalization of Rim1/2 and Cav2.2 was not possible because both primary
antibodies were raised in rabbit. Here we provided indirect evidence for the potential
enrichment of Cav2.2 in AZs in the following way. Using Rim1/2 labelling, we
demonstrated that 23.6% of the P-face membrane fragments fractured to large E-face
somatic membranes contain AZs. In Cav2.1 and Cav2.2 double labelling, this
proportion was almost identical (21.7%). The quantitative analysis of these double-
labelling reactions revealed that these two Ca2þ channels are almost fully exclusive:
92% of the fractured membranes had either Cav2.1 or Cav2.2 labelling. We also
delineated Cav2.2-rich areas of the boutons for illustrative purposes in our ﬁgures,
but we have no evidence that these areas fully overlap with the AZs.
Three-dimensional EM reconstruction of boutons. Three CCK-BAC/DsRedT3
mice (P19, P19 and P23, males) were perfused with ﬁxatives containing 2% PFA
and 0.5% glutaraldehyde in 0.1M sodium acetate buffer (pH¼ 6) for 2min, fol-
lowed by a 45-min perfusion with a ﬁxative containing 2% PFA and 0.5% glu-
taraldehyde in 0.1M sodium borate buffer (pH¼ 9). The brains were left in the
skull for 24 h at 4 C before removal. Horizontal sections (60 mm thick) were cut
from the ventral hippocampus with a vibratome, followed by several washes in PB
before treatment with 1% sodium borohydrate in PB for 30min. Sections were then
thoroughly washed in PB and TBS, followed by blocking in TBS containing 10%
NGS and incubation in mouse anti-CCK antibody (#9303 NIH, CURE/Digestive
Disease Research Center, University of California Los Angeles); diluted 1:1,000 in
TBS containing 2% NGS and 0.05% Triton X-100 at room temperature overnight.
After several washes in TBS, sections were incubated in biotinylated goat anti-
mouse secondary antibody in TBS. The reaction was then visualized with the
avidin–biotin–horseradish peroxidase complex and 303-diaminobenzidine tetra-
hydrochloride. Sections were then postﬁxed in 1% OsO4, stained in 1% uranyla-
cetate, dehydrated and embedded into Durcupan. Blocks containing the strata
pyramidale and radiatum of the distal CA3 area were re-embedded, and long series
of ultrathin sections were cut for EM. Series of digital images of randomly chosen
immunopositive boutons were taken from both layers. Boutons were reconstructed
in 3D using the Reconstruct software (http://synapses.clm.utexas.edu/) and the
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following ultrastructural parameters were measured: the surface and the volume of
the boutons, the number and volume of mitochondria in the boutons, the number
of AZs and the area of the AZs. The volume of the terminals was calculated by
deducing it with the total mitochondria volume.
Data analysis and statistical tests. Data were plotted using OriginPro 9.0
(OriginLab Corporation). Statistical tests were performed with Statistica 11 (Sci-
entiﬁc Computing). Shapiro–Wilk normality tests showed that the data sets were
not different from normal distributions, and therefore parametric statistical tests
(paired and unpaired t-test, randomized block design or factorial ANOVA with
Tukey’s post hoc test) were used as indicated in the manuscript. Spearman’s rank-
order correlation was used to assess correlations between variables if the sample
size was small (o30; Pearson’s correlation gave qualitatively same results in every
cases). For larger sample sizes (n470; Supplementary Fig. 7), Pearson’s correla-
tions were used if the data set did not deviate from a normal distribution. Results
were considered signiﬁcant at Po0.05. Data are presented as mean±s.d.
throughout the manuscript.
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In Fig. 1g of this Article, three data series were inadvertently omitted from the graph while the ﬁnal version of the manuscript was
prepared for submission. The correct version of Fig. 1 appears below.
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